You May Also Like

Safety and immunogenicity of a recombinant live attenuated tetravalent dengue vaccine (DENVax) in flavivirus-naive healthy adults in Colombia: a randomised, placebo-controlled, phase 1 study
Cite
CITE Title : Safety and immunogenicity of a recombinant live attenuated tetravalent dengue vaccine (DENVax) in flavivirus-naive healthy adults in Colombia: a randomised, placebo-controlled, phase 1 study Personal Author(s) : Osorio, Jorge E;Velez, Ivan D;Thomson, Cynthia;Lopez, Liliana;Jimenez, Alejandra;Haller, Aurelia A;Silengo, Shawn;Scott, Jaclyn;Boroughs, Karen L;Stovall, Janae L;Luy, Betty E;Arguello, John;Beatty, Mark E;Santangelo, Joseph;Gordon, Gilad S;Huang, Claire Y-H;Stinchcomb, Dan T; Published Date : July 23 2014;9-2014; Source : Lancet Infect Dis. 14(9):830-838 URL : https://stacks.cdc.gov/view/cdc/36659
• File Format:
Copy Export
• RIS
[PDF - 427.91 KB]
Personal Author:
Osorio, Jorge E ;
Velez, Ivan D
...
July 23 2014 | Lancet Infect Dis. 14(9):830-838
Description:
BackgroundDengue virus is the most serious mosquito-borne viral threat to public health and no vaccines or antiviral therapies are approved for dengue...
File Type:
[PDF - 427.91 KB]
File Type:
[PDF - 427.91 KB]

Development of DENVax: A chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever
Cite
CITE Title : Development of DENVax: A chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever Personal Author(s) : Osorio, Jorge E.;Huang, Claire Y.-H.;Kinney, Richard M.;Stinchcomb, Dan T.; Published Date : Jul 21 2011 Source : Vaccine. 29(42):7251-7260. URL : https://stacks.cdc.gov/view/cdc/34673
• File Format:
Copy Export
• RIS
[PDF - 513.75 KB]
Personal Author:
Osorio, Jorge E. ;
Huang, Claire Y.-H.
...
Jul 21 2011 | Vaccine. 29(42):7251-7260.
Description:
Dengue. virus infection is the leading arboviral cause of disease worldwide. A vaccine is being developed based on the attenuated DEN-2 virus, DEN-2 P...
File Type:
[PDF - 513.75 KB]
File Type:
[PDF - 513.75 KB]